Recent Finacing
Recent Raise
Alzeca Biosciences develops nanoparticle MRI contrast agents that bind abnormal brain proteins (e.g., amyloid) to enable earlier, radiation-free MRI diagnosis of Alzheimer’s and other neurodegenerative disorders.
Focus Areas
Total Raised
Funding round